NASDAQ:ATEC - Alphatec Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $14.33
  • Forecasted Upside: -3.61 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$14.87
▲ +0.53 (3.70%)
1 month | 3 months | 12 months
Get New Alphatec Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ATEC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ATEC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$14.33
▼ -3.61% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Alphatec in the last 3 months. The average price target is $14.33, with a high forecast of $20.00 and a low forecast of $9.00. The average price target represents a -3.61% upside from the last price of $14.87.
Buy
The current consensus among 6 polled investment analysts is to buy stock in Alphatec. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/30/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/26/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/25/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/24/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/22/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/21/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/13/2021Canaccord GenuityReiterated RatingBuy$16.00Low
i
12/21/2020HC WainwrightReiterated RatingBuy$12.00 ➝ $16.00High
i
12/18/2020Lake Street CapitalBoost Price Target$15.00 ➝ $20.00High
i
12/18/2020Canaccord GenuityBoost Price TargetBuy$12.00 ➝ $16.00High
i
10/19/2020Stifel NicolausInitiated CoverageBuy$13.00Medium
i
10/12/2020HC WainwrightBoost Price TargetBuy$9.00 ➝ $12.00Low
i
10/8/2020Lake Street CapitalBoost Price TargetBuy$13.00 ➝ $15.00High
i
10/8/2020Canaccord GenuityBoost Price TargetPositive ➝ Buy$9.00 ➝ $12.00High
i
9/3/2020CowenInitiated CoverageOutperform$12.00High
i
8/13/2020Canaccord GenuityReiterated RatingBuy$9.00Low
i
8/7/2020Canaccord GenuityReiterated RatingBuy$9.00High
i
6/18/2020Northland SecuritiesInitiated CoverageOutperform$9.00Medium
i
4/9/2020HC WainwrightReiterated RatingBuy$9.50 ➝ $7.50Medium
i
3/6/2020HC WainwrightReiterated RatingBuy$8.00 ➝ $9.50High
i
1/14/2020Lake Street CapitalBoost Price TargetBuy$10.00 ➝ $15.00Medium
i
1/14/2020HC WainwrightReiterated RatingBuyHigh
i
Rating by S. Ramakanth at HC Wainwright
10/31/2019Lake Street CapitalBoost Price TargetBuy$7.00 ➝ $10.00High
i
10/31/2019Piper Jaffray CompaniesBoost Price TargetOverweight$7.00 ➝ $9.00High
i
8/28/2019Canaccord GenuityInitiated CoverageBuy$7.00High
i
8/6/2019HC WainwrightBoost Price TargetBuy$4.00 ➝ $6.00Low
i
Rating by Swayampakula Ramakanth at HC Wainwright
8/5/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$7.00High
i
2/26/2019HC WainwrightSet Price TargetBuy$4.00Low
i
Rating by Swayampakula Ramakanth at HC Wainwright
1/14/2019HC WainwrightReiterated RatingBuy$4.00High
i
Rating by Swayampakula Ramakanth at HC Wainwright
11/12/2018HC WainwrightReiterated RatingBuy$4.00Low
i
Rating by Swayampakula Ramakanth at HC Wainwright
8/3/2018HC WainwrightReiterated RatingBuy$4.00High
i
Rating by Swayampakula Ramakanth at HC Wainwright
5/11/2018HC WainwrightSet Price TargetBuy$4.00High
i
Rating by Swayampakula Ramakanth at HC Wainwright
3/13/2018HC WainwrightSet Price TargetBuy$4.00High
i
Rating by Swayampakula Ramakanth at HC Wainwright
11/22/2017HC WainwrightReiterated RatingBuy$4.00N/A
i
Rating by S. Ramakanth at HC Wainwright
10/16/2017Lake Street CapitalInitiated CoverageBuy ➝ Buy$7.00N/A
i
8/14/2017HC WainwrightInitiated CoverageBuy ➝ Buy$4.00Medium
i
Rating by S. Ramakanth at HC Wainwright
3/14/2016Northland SecuritiesDowngradeOutperform ➝ UnderperformN/A
i
Rating by Mark Landy at Northland Securities
2/9/2016Northland SecuritiesDowngradeOutperform ➝ SellN/A
i
Rating by Mark Landy at Northland Securities
(Data available from 1/20/2016 forward)
Alphatec logo
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to meet the surgeon's needs and to maximize patient outcomes; LLICO access system, a minimally invasive posterior thoracolumbar access system; Invictus Spinal Fixation System, a comprehensive thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep designed to improve surgical efficiency without compromising accuracy. It also provides Arsenal spinal fixation system intended for posterior, non-cervical fixation in skeletally mature patients for treating degenerative disc disease, spondylolisthesis, fracture or dislocation, spinal stenosis, curvatures, tumor, pseud arthrosis, and failed previous fusion; zodiac degenerative spinal fixation system, a comprehensive spinal system used to address degenerative spinal conditions and deformity correction; OsseoScrew system to restore the integrity of the spinal column; trestle luxe anterior cervical plate system; and solanas posterior cervico/thoracic fixation system and avalon occipital plate. In addition, the company offers IdentiTi Porous Ti and Transcend Lateral Interbody Implants; Battalion PC; Novel SD; Solus Anterior Lumbar Interbody Fusion System. Further, it is developing EOS imaging products. Additionally, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Read More

Today's Range

Now: $14.87
$14.28
$14.87

50 Day Range

MA: $13.21
$10.23
$14.63

52 Week Range

Now: $14.87
$2.19
$14.97

Volume

541,254 shs

Average Volume

756,505 shs

Market Capitalization

$1.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.53

Frequently Asked Questions

What sell-side analysts currently cover shares of Alphatec?

The following sell-side analysts have issued reports on Alphatec in the last year: Canaccord Genuity, Cowen Inc, HC Wainwright, Lake Street Capital, Northland Securities, Stifel Nicolaus, and Zacks Investment Research.

What is the current price target for Alphatec?

6 Wall Street analysts have set twelve-month price targets for Alphatec in the last year. Their average twelve-month price target is $14.33, suggesting a possible downside of 3.6%. Lake Street Capital has the highest price target set, predicting ATEC will reach $20.00 in the next twelve months. Northland Securities has the lowest price target set, forecasting a price of $9.00 for Alphatec in the next year.

What is the current consensus analyst rating for Alphatec?

Alphatec currently has 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ATEC will outperform the market and that investors should add to their positions of Alphatec.

What other companies compete with Alphatec?

How do I contact Alphatec's investor relations team?

Alphatec's physical mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company's listed phone number is 760-431-9286 and its investor relations email address is ir@alphatecspine.com. The official website for Alphatec is www.atecspine.com.